Phase I dose-escalation results of prostate-specific membrane antigen-targeted radionuclide therapy (PSMA-TRT) with alpha-radiolabeled antibody 225 Ac-J591 and beta-radioligand 177 Lu-PSMA I&T.

Tagawa, Scott T., Sun, Michael Philip, Nauseef, Jones T. · Journal of Clinical Oncology · 2023